UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
UBS analyst Josh Silverstein maintains Helmerich & Payne (NYSE:HP) with a Buy and raises the price target from $49 to $50.
UBS analyst Josh Silverstein maintains Helmerich & Payne (NYSE:HP) with a Buy and raises the price target from $49 to $50.